Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
11025449 | Critical Reviews in Oncology/Hematology | 2018 | 36 Pages |
Abstract
FDG-PET(/CT) is currently the most frequently investigated imaging modality in PTLD patients. Available studies report promising results in detection, staging and therapy evaluation but suffer from methodological shortcomings. Concerns remain with regard to occurrence of false negatives due to physiological high background activity and early PTLD lesions as well as false positives due to inflammatory conditions.
Keywords
DLBCLNPVQUADAS-2TLGMTVBMBSUVmaxR-CHOPPTLDFDGPPVPost-transplant lymphoproliferative disorderpositive predictive valuenegative predictive valuequality assessment of diagnostic accuracy studiesMRIEBVBone marrow biopsyMagnetic resonanceMagnetic resonance imagingcomputed tomographyPositron emission tomographyMetabolic tumor volumemaximum standardized uptake valueCNSWorld Health Organizationcentral nervous systemDiffuse large B-cell lymphomaEpstein barr virusPETcontrast enhanced computed tomographyWHOtotal lesion glycolysis
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
F.M. Montes de Jesus, T.C. Kwee, M. Nijland, X.U. Kahle, G. Huls, R.A.J.O. Dierckx, T. van Meerten, O. Gheysens, D. Dierickx, V. Vergote, W. Noordzij, A.W.J.M. Glaudemans,